Related Experiment Videos
Gastro-oesophageal reflux in children
1Department of Child Health, Singleton Hospital, Sketty, Swansea, UK.
Insights
Pediatric gastrointestinal motility disorders often present as gastro-oesophageal reflux disease. Management ranges from lifestyle adjustments and medication to surgery for severe, refractory cases.
Area of Science:
- Pediatric Gastroenterology
- Gastrointestinal Motility Disorders
Background:
- Gastrointestinal motility disorders in children commonly manifest as gastro-oesophageal reflux disease (GERD).
- While GERD is frequent in infants, it often resolves spontaneously.
- Severe cases necessitate investigations like 24-hour ambulatory esophageal pH monitoring or upper endoscopy.
Discussion:
- Esophagitis diagnosis may require upper gastrointestinal endoscopy and biopsy.
- Treatment strategies are tiered, starting with conservative measures.
- Pharmacological interventions include prokinetic agents and acid suppression.
Key Insights:
- Disordered GI motility in children frequently presents as GERD.
- Diagnostic tools include pH monitoring and endoscopy.
- Treatment is stepwise, from conservative to surgical options.
Outlook:
- Further research into optimizing diagnostic accuracy and therapeutic efficacy for pediatric GERD is warranted.
- Exploring novel therapeutic targets for refractory cases could improve outcomes.
- Long-term follow-up studies are essential to understand the natural history and impact of interventions.
Abstract:
Disordered motility of the gastrointestinal tract in children is usually manifest as gastro-oesophageal reflux disease. Reflux is common in infants but usually resolves spontaneously with time. If severe enough to merit investigation, 24-hour ambulant oesophageal pH monitoring is the most widely used investigation, though it does have disadvantages. Upper gastrointestinal endoscopy and biopsy may be required to diagnose oesophagitis. Treatment follows a step-wise approach, progressing from positioning and feed-thickening in infants, through to pharmacological management with prokinetic agents and/or acid-suppression, and surgery for a very small proportion of children whose symptoms do not respond to optimal medical therapy.